|
Volumn 7, Issue 1, 1997, Pages 43-54
|
Neurokinin receptor antagonists
|
Author keywords
Neurokinin; Substance P; Tachykinin
|
Indexed keywords
2 BENZYL 1 (3,5 DIMETHYLBENZOYL) 4 (4 QUINOLINYLMETHYLAMINO)PIPERIDINE;
3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE;
3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE;
3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE;
4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL;
[2 METHOXY 5 (1 TETRAZOLYL)BENZYL](2 PHENYL 3 PIPERIDINYL)AMINE;
DIAMINE DERIVATIVE;
FK 224;
INDOLE DERIVATIVE;
LANEPITANT;
MDL 105212;
MORPHOLINE DERIVATIVE;
N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE;
NEUROKININ 1 RECEPTOR;
NEUROKININ 1 RECEPTOR ANTAGONIST;
NEUROKININ 2 RECEPTOR;
NEUROKININ 2 RECEPTOR ANTAGONIST;
NEUROKININ 3 RECEPTOR;
NEUROKININ 3 RECEPTOR ANTAGONIST;
NOLPITANTIUM;
ONDANSETRON;
PIPERIDINE;
RECEPTOR SUBTYPE;
RPR 107880;
RPR 111905;
TACHYKININ RECEPTOR;
TACHYKININ RECEPTOR ANTAGONIST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VOFOPITANT;
ZD 7944;
ANXIETY;
ARTHRITIS;
ASTHMA;
CANCER;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG RESEARCH;
GLAUCOMA;
HUMAN;
INTRAOCULAR HYPOTENSION;
MIGRAINE;
NERVE CELL LESION;
NONHUMAN;
PAIN;
PATENT;
REVIEW;
SCHIZOPHRENIA;
STROKE;
VOMITING;
|
EID: 0030849519
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.7.1.43 Document Type: Review |
Times cited : (29)
|
References (44)
|